Myeloid Leukemia — Trials

Myeloid Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

3,528 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 862
Recruiting: 498
Ph III recruiting: 47
Growth YoY: +4.1%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (617)

clinicaltrialsPublishedShowing 151–200 of 1,516 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05143840	Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase(ALERTCML)	active not recruiting	Phase 2	100	University of Alabama at BirminghamOTHER	1	Jul 22, 2026	clinicaltrials
NCT06013423	Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases	recruiting	Phase 2	54	Fred Hutchinson Cancer CenterOTHER	1	Jul 22, 2026